Immunogenetics of chronic lymphocytic leukemia

Area of Science:

• Hematology
• Oncology
• Immunogenetics

Background:

• Clinical heterogeneity in Chronic Lymphocytic Leukemia (CLL) is linked to cytogenetic aberrations and IGVH mutations.
• Geographical variations exist in IGVH mutation status and gene usage.
• This is the first study to investigate the immunogenetics of CLL in India.

Purpose of the Study:

• To document the immunogenetics of CLL in an Indian cohort.
• To analyze IGVH mutation status, VH gene usage, and cytogenetic abnormalities.
• To correlate these findings with clinical variables in 84 CLL patients.

Main Methods:

• Analysis of IGVH mutation status and VH gene usage.
• Detection of cytogenetic abnormalities using Fluorescence In Situ Hybridization (FISH).
• Immunophenotyping and correlation with clinical variables.

Main Results:

• 55.2% of patients had unmutated IGVH, associated with higher CD38/CD49d expression, advanced Rai stage, and p53 deletions.
• 13q deletion was the most common cytogenetic abnormality (48.4%).
• Unmutated IGVH cases showed a higher likelihood of requiring treatment.

Conclusions:

• A higher proportion of unmutated IGVH patients (55.2%) were observed in the Indian cohort.
• Commonly used VH genes include IGVH 2-5, IGVH 1-2, and IGVH 1-69.
• Longer follow-up and larger cohorts are needed to confirm the prognostic value of IGVH mutation analysis in Indian CLL patients.